Glass House Brands (GLAS) Preferred Dividend Payments (2022 - 2026)
Glass House Brands (GLAS) posted quarterly Preferred Dividend Payments of -$2.9 million for Q1 2026, down 49.02% year-over-year from -$5.7 million in Q1 2025, and down 49.1% quarter-over-quarter from -$1.9 million in Q3 2025.
Glass House Brands (GLAS) Preferred Dividend Payments (2022 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Preferred Dividend Payments for 5 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments fell 49.02% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$8.7 million (down 12.27% YoY), while the FY2022 annual figure was $1.1 million, up 163.15% from the prior year.
- Preferred Dividend Payments fell to -$2.9 million in Q1 2026 per GLAS's latest filing, from -$1.9 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.4 million in Q2 2023 and bottomed at -$2.9 million in Q1 2026.
- Historically, Preferred Dividend Payments has averaged -$1.0 million across 5 years, with a median of -$1.8 million in 2023.
- On a YoY basis, Preferred Dividend Payments climbed as much as 60.0% in 2023 and fell as far as 257.18% in 2023.
- Glass House Brands' Preferred Dividend Payments stood at $1.1 million in 2022, then plunged by 245.07% to -$1.6 million in 2023, then decreased by 17.7% to -$1.9 million in 2024, then gained by 0.05% to -$1.9 million in 2025, then plunged by 49.1% to -$2.9 million in 2026.
- Business Quant data shows GLAS's Preferred Dividend Payments at -$2.9 million in Q1 2026, -$1.9 million in Q3 2025, and -$1.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | -2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.89 Mn |
| Sep 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | -1.94 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -1.94 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | -1.37 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | 860,000.00 |
| Mar 31, 2022 | 870,000.00 |